NOLA.com5h
The first bone marrow transplant in Baton Rouge in 8 years rings bell for cancer survivors
The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...
How blood and bone marrow transplant expertise is changing cancer care at Ohio State
For four decades, Ohio State blood and bone marrow transplant innovation has improved cancer care with an increasing emphasis ...
Business Wire2h
Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program
Omeros Corporation (Nasdaq: OMER) today announced two presentations that will be featured at the 2025 Tandem Meetings – the ...
CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the ...
Upstate cancer survivor celebrates recovery with innovative CAR T-cell treatment
On this World Cancer Day, Chris Vogelsang, a cancer survivor from upstate New York, is celebrating his recovery thanks to a ...
Managed Healthcare Executive4d
Grafapex Approved for Reduced-Intensity Stem Cell Transplants in AML and MDS Patients
Treosulfan (Grafapex) was approved in Canada in June 2021 for the same use and is marketed under the brand name Trecondyv.
The Pharma Letter12d
Sarclisa wins MHRA nod for newly-diagnosed multiple myeloma
Days after the European Commission (EC) granted approval, the UK’s Medicines and Healthcare Regulatory Agency (MHRA) has ...
News Medical on MSN12d
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Fred Hutch news release clinical trial shows fecal microbiota transplantation helped with gut microbiome recovery in patients after stem cell transplantation ...
Carsgen's First Enrolled Subject In The THANK-U Plustm Platform-Based Allogeneic CAR-T Trial Achieves Scr At Week 4
CARsgen Therapeutics Holdings Limited (Stock Code: 2171), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the first ...